As an enrichment strategy supplemented by the diagnostic framework of subjective cognitive decline (SCD), SCD plus identifies features that may increase the likelihood of including future-Alzheimer’s disease (AD) patients. This study aimed to identify the shared and distinct atrophy patterns between patients specified by SCD plus and amnestic mild cognitive impairment (aMCI, a prodromal stage of AD) and to investigate the extent that automated brain magnetic resonance imaging (MRI) volumetry can differentiate patients with SCD from normal control (NC) participants and patients with aMCI. We acquired structural MRI brain scans from 44 patients with aMCI, 40 patients with SCD (who met the major criteria of SCD plus), and 48 NC participants. Automatic brain segmentation was performed to quantify the volumetric measures of cognitive-relevant areas. These volumetric measures were compared across the 3 groups with analysis of variance. In addition, we performed support vector machine analyses using volumetric measures of single regions or multiple regions to further evaluate the sensitivity of automated brain volumetry in differentiating a specific group from another. The atrophy patterns in patients with aMCI and SCD were similar. Using the regional volumetric measures, we achieved high performance in differentiating aMCI and SCD from NCs (average classification accuracy [ACC] > 90%). However, the performance was not ideal when differentiating aMCI from SCD (ACC < 63%). In conclusion, patients with SCD specified by SCD plus presented similar atrophy patterns as patients with aMCI, which was distinguishable from NC participants. Future studies should aim to associate the atrophy patterns of SCD with possible conversion to aMCI or AD in a longitudinal design.
GauthierSReisbergBZaudigM, et al.Mild cognitive impairment. Lancet. 2006;367(9518):1262–1270.
2.
JessenFAmariglioREvan BoxtelM, et al.A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer’s disease. Alzheimers Dement. 2014;10(6):844–852.
3.
LuckTLuppaMMatschingerHJessenFAngermeyerMCRiedel-HellerSG. Incident subjective memory complaints and the risk of subsequent dementia. Acta Psychiatr Scand. 2015;131(4):290–296.
4.
Lopez-SanzDBrunaRGarcesP, et al.Functional connectivity disruption in subjective cognitive decline and mild cognitive impairment: a common pattern of alterations. Front Aging Neurosci. 2017;9:109.
5.
ColijnMAGrossbergGT. Amyloid and Tau biomarkers in subjective cognitive impairment. J Alzheimers Dis. 2015;47(1):1–8.
6.
StriepensNScheefLWindA, et al.Volume loss of the medial temporal lobe structures in subjective memory impairment. Dement Geriatr Cogn Disord. 2010;29(1):75–81.
7.
RogneSVangbergTEldevikPWikranGMathiesenEBSchirmerH. Magnetic resonance volumetry: prediction of subjective memory complaints and mild cognitive impairment, and associations with genetic and cardiovascular risk factors. Dement Geriatr Cogn Dis Extra. 2016;6(3):529–540.
8.
SaykinAJWishartHARabinLA, et al.Older adults with cognitive complaints show brain atrophy similar to that of amnestic MCI. Neurology. 2006;67(5):834–842.
9.
StewartRDufouilCGodinO, et al.Neuroimaging correlates of subjective memory deficits in a community population. Neurology. 2008;70(18):1601–1607.
10.
PeterJScheefLAbdulkadirA, et al.Gray matter atrophy pattern in elderly with subjective memory impairment. Alzheimers Dement. 2014;10(1):99–108.
11.
DavatzikosCFanYWuXShenDResnickSM. Detection of prodromal Alzheimer’s disease via pattern classification of magnetic resonance imaging. Neurobiol Aging. 2008;29(4):514–523.
12.
DesikanRSCabralHJHessCP, et al.Automated MRI measures identify individuals with mild cognitive impairment and Alzheimer’s disease. Brain. 2009;132(pt 8):2048–2057.
13.
RathoreSHabesMIftikharMAShacklettADavatzikosC. A review on neuroimaging-based classification studies and associated feature extraction methods for Alzheimer’s disease and its prodromal stages. Neuroimage. 2017;155:530–548.
14.
MolinuevoJLRabinLAAmariglioR, et al.Implementation of subjective cognitive decline criteria in research studies. Alzheimers Dement. 2017;13(3):296–311.
15.
WolfsgruberSKleineidamLWagnerM, et al.Differential risk of incident Alzheimer’s Disease dementia in stable versus unstable patterns of subjective cognitive decline. J Alzheimers Dis. 2016;54(3):1135–1146.
16.
PetersenRC. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004;256(3):183–194.
17.
HanYWangJZhaoZ, et al.Frequency-dependent changes in the amplitude of low-frequency fluctuations in amnestic mild cognitive impairment: a resting-state fMRI study. Neuroimage. 2011;55(1):287–295.
18.
LiYWangXLiY, et al.Abnormal resting-State functional connectivity strength in mild cognitive impairment and its conversion to Alzheimer’s disease. Neural Plast. 2016;2016:4680972.
19.
AbrigoJShiLLuoY, et al.Standardization of hippocampus volumetry using automated brain structure volumetry tool for an initial Alzheimer’s disease imaging biomarker. Acta Radiol. 2018;60(6):769–776. 284185118795327.
20.
WhitwellJLCrumWRWattHCFoxNC. Normalization of cerebral volumes by use of intracranial volume: implications for longitudinal quantitative MR imaging. Am J Neuroradiol. 2001;22(8):1483–1489.
ChangC-CLinC-J. LIBSVM: a library for support vector machines. ACM Trans Intell Syst Technol. 2011;2(3):1–27.
23.
CasanovaRWhitlowCTWagnerB, et al.High dimensional classification of structural MRI Alzheimer’s disease data based on large scale regularization. Front Neuroinform. 2011;5(22):22.
24.
KrstajicDButurovicLJLeahyDEThomasS. Cross-validation pitfalls when selecting and assessing regression and classification models. J Cheminform. 2014;6(1):10.
25.
HuangJLingCX. Using AUC and accuracy in evaluating learning algorithms. IEEE Trans Knowl Data Eng. 2005;17(3):299–310.
26.
KhandokerAHPalaniswamiMKarmakarCK. Support vector machines for automated recognition of obstructive sleep apnea syndrome from ECG recordings. IEEE Trans Inf Technol Biomed. 2009;13(1):37–48.
27.
NamB-HD’AgostinoRB. Discrimination index, the area under the ROC curve. In: Huber-CarolCBalakrishnanNNikulinMSMesbahM, eds. Goodness-of-Fit Tests and Model Validity. Berlin, Germany: Springer; 2002:267–279.
28.
VaughanIOrmerodS. The continuing challenges of testing species distribution models. J Appl Ecol. 2005;42(4):720–730.
29.
LoboJMJiménez-ValverdeARealR. AUC: a misleading measure of the performance of predictive distribution models. Glob Ecol Biogeogr. 2008;17(2):145–151.
30.
MoradiEPepeAGaserCHuttunenHTohkaJ, Alzheimer’s Disease Neuroimaging Initiative. Machine learning framework for early MRI-based Alzheimer’s conversion prediction in MCI subjects. Neuroimage. 2015;104:398–412.
31.
KovacevicSRafiiMSBrewerJB, Alzheimer’s Disease Neuroimaging Initiative. High-throughput, fully automated volumetry for prediction of MMSE and CDR decline in mild cognitive impairment. Alzheimer Dis Assoc Disord. 2009;23(2):139–145.
32.
HamalainenATervoSGrau-OlivaresM, et al.Voxel-based morphometry to detect brain atrophy in progressive mild cognitive impairment. Neuroimage. 2007;37(4):1122–1131.
33.
McEvoyLKFennema-NotestineCRoddeyJC, et al.Alzheimer disease: quantitative structural neuroimaging for detection and prediction of clinical and structural changes in mild cognitive impairment. Radiology. 2009;251(1):195–205.
34.
KakedaSKorogiY. The efficacy of a voxel-based morphometry on the analysis of imaging in schizophrenia, temporal lobe epilepsy, and Alzheimer’s disease/mild cognitive impairment: a review. Neuroradiology. 2010;52(8):711–721.
35.
VerfaillieSCTijmsBVersteegA, et al.Thinner temporal and parietal cortex is related to incident clinical progression to dementia in patients with subjective cognitive decline. Alzheimers Dement. 2016;5:43–52.
36.
PerrotinALa JoieRde La SayetteV, et al.Subjective cognitive decline in cognitively normal elders from the community or from a memory clinic: differential affective and imaging correlates. Alzheimers Dement. 2017;13(5):550–560.
37.
WangXNZengYChenGQ, et al.Abnormal organization of white matter networks in patients with subjective cognitive decline and mild cognitive impairment. Oncotarget. 2016;7(31):48953–48962.
38.
CarmichaelOTKullerLHLopezOL, et al.Cerebral ventricular changes associated with transitions between normal cognitive function, mild cognitive impairment, and dementia. Alzheimer Dis Assoc Disord. 2007;21(1):14–24.
39.
JessenFWieseBBachmannC, et al.Prediction of dementia by subjective memory impairment: effects of severity and temporal association with cognitive impairment. Arch Gen Psychiatry. 2010;67(4):414–422.
40.
SørensenLIgelCLiv HansenN, et al.Early detection of Alzheimer’s disease using MRI hippocampal texture. Hum Brain Mapp. 2016;37(3):1148–1161.
41.
ChincariniABoscoPCalviniP, et al.Local MRI analysis approach in the diagnosis of early and prodromal Alzheimer’s disease. Neuroimage. 2011;58(2):469–480.
